Pharmacology Quiz 2 NU 160

Correct Answer C: Dry mouth

Explanation of the Correct Answer:

Ipratropium is an anticholinergic medication commonly used in the management of chronic obstructive pulmonary disease (COPD) and asthma. A common side effect of anticholinergic medications, including ipratropium, is dry mouth. This occurs due to the inhibition of acetylcholine, which reduces salivation. Clients should be informed that this is a typical and manageable side effect.

Why the Other Options Are Incorrect:

A. Drowsiness

Incorrect. Ipratropium is not known to cause drowsiness. It is a bronchodilator and does not have sedative effects, which makes drowsiness an uncommon side effect.

B. Muscle tremors

Incorrect. Muscle tremors are more commonly associated with medications like beta-agonists (e.g., albuterol), not ipratropium. Ipratropium does not typically cause muscle tremors.

D. Increased salivation

Incorrect. Ipratropium works by blocking acetylcholine, leading to a decrease in salivation, not an increase. Increased salivation is not a side effect of ipratropium.

Summary:

The nurse should inform the client that dry mouth is a common side effect of ipratropium and advise the client on ways to manage it, such as drinking water or using sugar-free gum or lozenges.

Correct Answers:

B. Redness or mild pain at the injection site is a common side effect.

C. Patients should monitor for signs of infection after self-injection.

E. Adalimumab can lead to reactivation of tuberculosis.

Explanation of the Correct Answers:

B. Redness or mild pain at the injection site is a common side effect.

This is a well-known side effect of subcutaneous injections, including adalimumab. The injection can cause localized redness, mild pain, swelling, or itching at the site. This is usually temporary and resolves on its own.

C. Patients should monitor for signs of infection after self-injection.

Adalimumab, like other biologic medications, can increase the risk of infections. Because it suppresses the immune system, patients should be vigilant and monitor for symptoms such as fever, redness, or swelling at the injection site, or signs of systemic infection like chills or cough.

E. Adalimumab can lead to reactivation of tuberculosis.

Adalimumab can suppress the immune system and potentially reactivate latent tuberculosis (TB) infections. Patients are often screened for TB prior to starting adalimumab therapy to reduce the risk of reactivation.

Why the Other Options Are Incorrect:

A. The injection site should be kept moist to prevent infection.

Incorrect. The injection site should be kept clean and dry. Moisture can increase the risk of infection, and patients should follow proper cleaning techniques before administering the injection. Typically, alcohol wipes are used to clean the skin prior to injection.

D. Infections are not a concern with adalimumab treatment.

Incorrect. Infections are a significant concern with adalimumab therapy because it suppresses the immune system, increasing the risk of both local and systemic infections. This is why infection monitoring is crucial during treatment.

F. The medication should be injected into the muscle of the upper arm.

Incorrect. Adalimumab is typically administered subcutaneously, not intramuscularly. Common injection sites include the abdomen or the front of the thigh. Injecting into the muscle of the upper arm is not the recommended method.

Summary:

The true statements regarding adalimumab's side effects and self-injection technique are: redness or mild pain at the injection site is common, patients should monitor for signs of infection, and adalimumab can lead to reactivation of tuberculosis. Proper injection technique and infection monitoring are essential components of safe adalimumab use.

Correct Answer C: Renal stones

Explanation of the Correct Answer:

Calcium supplements are commonly prescribed for clients with osteoporosis to support bone mineral density and reduce fracture risk. However, one of the known adverse effects of calcium supplementation—particularly in high doses or when combined with inadequate fluid intake—is the development of renal (kidney) stones. These stones typically form when there is an excess of calcium excreted into the urine (hypercalciuria), leading to crystallization and the eventual formation of calcium oxalate or calcium phosphate stones.

The hallmark symptom of renal stones is flank pain, which can be severe, sharp, and radiating toward the lower abdomen or groin, depending on the stone’s location within the urinary tract. Clients may also report associated symptoms such as hematuria, nausea, vomiting, or dysuria. This presentation should prompt the nurse to suspect nephrolithiasis as a possible complication of calcium supplementation.

Why the Other Options Are Incorrect:

A. Hepatitis

Incorrect. Hepatitis involves inflammation of the liver and is not associated with calcium supplementation. It typically presents with right upper quadrant abdominal pain, jaundice, and abnormal liver function tests, not flank pain.

B. Hip fracture

Incorrect. Hip fractures are a complication of osteoporosis itself and not a result of taking calcium. In fact, calcium supplementation is intended to help prevent fractures. Additionally, hip fractures would present with localized hip or groin pain, not flank pain.

D. Pancreatitis

Incorrect. While extremely high levels of calcium (as seen in hyperparathyroidism) can rarely trigger pancreatitis, this is not a common side effect of calcium supplements alone. Pancreatitis is characterized by epigastric pain that may radiate to the back, not flank pain, making this an unlikely explanation in this case.

Summary:

The client’s report of flank pain while taking a daily calcium supplement is most consistent with renal stones, a known adverse effect of calcium supplementation due to its potential to increase urinary calcium and promote stone formation

Correct Answer D: Avoid driving until effects are known.

Explanation of the Correct Answer:

Cyclobenzaprine is a centrally acting skeletal muscle relaxant commonly prescribed to treat acute muscle spasms associated with musculoskeletal conditions. It works by depressing motor activity primarily in the brainstem, leading to muscle relaxation. One of the most important safety considerations when starting cyclobenzaprine is its sedative effect, which can cause drowsiness, dizziness, and impaired cognitive or motor performance.

Because of these central nervous system effects, clients are advised to avoid driving, operating heavy machinery, or engaging in hazardous activities until they understand how the drug affects them individually. This is particularly crucial during the initial stages of treatment or when the dose is increased, as sedation may be pronounced.

Why the Other Options Are Incorrect:

A. Monitor for increased muscle spasms

Incorrect. Cyclobenzaprine is used to reduce muscle spasms, not increase them. If spasms worsen, it may indicate an ineffective response, but it is not a common or expected adverse effect of the drug.

B. Discontinue medication if nausea occurs.

Incorrect. Nausea is a relatively mild and non-life-threatening side effect of cyclobenzaprine. It should not be a reason for abrupt discontinuation. Instead, clients should report persistent or severe nausea to their provider, who may adjust the dose or provide supportive measures.

C. Expect urine to turn orange

Incorrect. Orange discoloration of urine is associated with medications like phenazopyridine, not cyclobenzaprine. This is not an expected or typical side effect of this muscle relaxant.

Summary:

The nurse should teach the client to avoid driving until the effects of cyclobenzaprine are known, due to its potential to cause sedation and impair motor and cognitive function, especially during the initial treatment period.

Correct Answer D: I have an increased risk of getting pneumonia while taking this medication.

Explanation of the Correct Answer:

Esomeprazole is a proton pump inhibitor (PPI) used to reduce gastric acid production, commonly prescribed for gastroesophageal reflux disease (GERD), peptic ulcers, and other acid-related conditions. While effective, long-term use of PPIs like esomeprazole can lead to several adverse effects, one of which is an increased risk of pneumonia.

PPIs reduce the acidity of the stomach, which diminishes the natural defense against ingested pathogens. With less acid to kill bacteria, organisms can more easily travel to the respiratory tract, especially in older adults or hospitalized patients, increasing the risk of community-acquired or aspiration pneumonia.

Why the Other Options Are Incorrect:

A. I won’t pass gas as often now that I am taking this medication.

Incorrect. Esomeprazole may help reduce bloating or indigestion in some cases, but passing gas (flatulence) is not a specific target or guaranteed effect of this medication.

B. I will need to take a daily stool softener while taking this medication.

Incorrect. While constipation may occur in some individuals, it is not common enough to justify routine stool softener use unless prescribed. Patients should manage bowel changes based on symptoms.

C. I will take this medication each morning with my breakfast.

Incorrect. Esomeprazole should be taken at least 1 hour before a meal, typically in the morning, on an empty stomach, for maximum effectiveness. Taking it with food can reduce absorption.

Summary:

The statement that best shows understanding is D, recognizing that esomeprazole increases the risk of pneumonia, which is a known and important potential side effect of long-term PPI use.

Correct Answer:

A. The medication will open the airways.

D. The medication will prevent wheezing.

E. The medication will decrease coughing episodes.

Explanation of the Correct Answers:

A. The medication will open the airways.

Albuterol is a beta-2 agonist that works by relaxing the smooth muscles around the airways, leading to bronchodilation. This helps open the airways, making it easier for the person to breathe, which is why albuterol is used in the treatment of conditions like asthma and COPD.

D. The medication will prevent wheezing.

By opening the airways, albuterol can prevent wheezing, which is commonly caused by constricted or narrowed airways. Wheezing is a hallmark symptom of asthma and other respiratory conditions, and albuterol helps alleviate it by improving airflow.

E. The medication will decrease coughing episodes.

Although albuterol is primarily used to alleviate wheezing and shortness of breath by opening the airways, it can indirectly reduce coughing episodes as well. This is because coughing can often be triggered by constricted or narrowed airways, and by improving airflow, albuterol can make breathing easier, thus reducing coughing that may be associated with bronchoconstriction.

Why the Other Options Are Incorrect:

B. The medication will reduce inflammation.

Albuterol is a bronchodilator, not an anti-inflammatory drug. While it helps open up the airways, it does not directly reduce inflammation in the airways. Medications like steroids are used for that purpose, but albuterol itself does not have an anti-inflammatory effect.

C. The medication will stimulate flow of mucus.

Albuterol does not stimulate mucus production. It works by relaxing the muscles of the airways to allow for easier breathing, but it does not directly affect mucus production or clearance. Mucus flow and secretion are typically managed by other types of treatments, such as expectorants.

Summary:

Albuterol opens the airways, prevents wheezing, and can reduce coughing by improving airflow. It does not directly reduce inflammation or stimulate mucus flow. Therefore, the correct answers are A, D, and E.

Correct Answers:

A. Clients should avoid live vaccines while on immunomodulator therapy.

C. Regular follow-up visits and bloodwork are essential for monitoring health status.

E. Clients should report any signs of infection immediately, such as fever or unusual fatigue.

Explanation of the Correct Answers:

Azathioprine is an immunosuppressant often used to treat autoimmune conditions like inflammatory bowel disease (IBD) and rheumatoid arthritis, and to prevent organ transplant rejection. Because it suppresses the immune system, specific safety precautions and monitoring are essential.

A. Clients should avoid live vaccines while on immunomodulator therapy.

Correct. Live vaccines (such as MMR, varicella, and intranasal flu vaccine) can pose a serious risk of infection in immunosuppressed individuals. Clients should be instructed to avoid live vaccines unless cleared by their healthcare provider.

C. Regular follow-up visits and bloodwork are essential for monitoring health status.

Correct. Azathioprine can cause bone marrow suppression, liver toxicity, and increased infection risk. Regular CBCs and liver function tests are essential to monitor for leukopenia, anemia, or hepatotoxicity.

E. Clients should report any signs of infection immediately, such as fever or unusual fatigue.

Correct. Because azathioprine weakens the immune system, clients are at increased risk of infections. Fever, sore throat, or unexplained fatigue should be reported immediately, as they may indicate a serious infection.

Why the Other Options Are Incorrect:

B. It is safe to receive live vaccines if administered at least 30 days after starting the medication.

Incorrect. Live vaccines are generally contraindicated during immunosuppressive therapy regardless of timing, unless specifically advised by a specialist.

D. Handwashing is not necessary if the client avoids sick individuals.

Incorrect. Frequent handwashing is essential for infection prevention, especially when the immune system is compromised. Avoiding sick individuals is not a substitute for good hygiene practices.

F. Clients can discontinue their medication if they feel well after a few weeks.

Incorrect. Azathioprine must be taken consistently as prescribed. Stopping without medical guidance can lead to relapse or rejection in transplant patients. Always consult a healthcare provider before making changes.

Summary:

Correct patient teaching for azathioprine includes avoiding live vaccines, attending regular bloodwork appointments, and promptly reporting infection signs. Stopping the medication without medical advice or neglecting hygiene are unsafe practices.

Correct Answer:

A. Jaw pain

B. Tinnitus

C. Blurred vision

D. Dysphagia

Explanation of the Correct Answers:

A. Jaw pain:

Jaw pain is a serious side effect associated with bisphosphonates like alendronate, particularly because it can be a sign of osteonecrosis of the jaw. This condition is a rare but severe complication that can result from bisphosphonate therapy and requires prompt medical attention.

B. Tinnitus:

Tinnitus (ringing in the ears) is a possible side effect of alendronate, though it is not very common. It could indicate an issue with the medication and should be reported to the healthcare provider.

C. Blurred vision:

Blurred vision can be a sign of ocular toxicity, which, although rare, is a potential adverse effect of alendronate. If the client experiences any vision changes, it should be reported to the provider.

D. Dysphagia:

Dysphagia (difficulty swallowing) is a known side effect of bisphosphonates like alendronate, especially if the medication is not taken with sufficient water or the client lies down shortly after taking it. Difficulty swallowing could lead to esophageal irritation or even ulceration, so it is important to report this to the provider.

Why the Other Option Is Incorrect:E. Drowsiness:

Drowsiness is not a common or serious side effect of alendronate. It is not typically associated with the medication, and unless the client experiences extreme fatigue or unusual symptoms, drowsiness does not need to be reported.

Summary:

The nurse should instruct the client to report jaw pain, tinnitus, blurred vision, and dysphagia as these can indicate serious adverse effects like osteonecrosis of the jaw, ocular toxicity, or esophageal irritation. Drowsiness is not a typical side effect of alendronate and does not require immediate attention unless other symptoms develop.

Correct Answer C: Reduced dyspepsia

Explanation of the Correct Answer:

Omeprazole is a proton pump inhibitor (PPI) that works by reducing gastric acid production. It is commonly prescribed to treat conditions like gastroesophageal reflux disease (GERD), peptic ulcers, and dyspepsia (indigestion). Reduced dyspepsia—which includes symptoms like heartburn, bloating, and discomfort after eating—is a clear indication that omeprazole is effective in decreasing gastric acid secretion and improving the client's symptoms.

Why the Other Options Are Incorrect:

A. Regular bowel movements

Incorrect. Omeprazole does not directly affect bowel movements. While it may help with stomach acid, it is not intended to regulate bowel function.

B. Increased appetite

Incorrect. Omeprazole does not typically cause increased appetite. If a client experiences changes in appetite, other factors should be considered, such as medication side effects or underlying conditions.

D. Absence of headache

Incorrect. Headaches are not a primary symptom of the conditions that omeprazole treats, and the absence of a headache is not a direct indicator of the medication's effectiveness.

Summary:

The most appropriate indicator of omeprazole's effectiveness in this case is reduced dyspepsia, as the drug is designed to alleviate symptoms related to excessive stomach acid.